WestEnd Advisors’s West Pharmaceutical WST Stock Holding History

WestEnd Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$752	Hold	3	–	–	﹤0.01%	276
2025 Q4	$825	Buy	3 +1	+50%	+$274	﹤0.01%	260
2025 Q3	$525	Sell	2 -1	-33%	-$243	﹤0.01%	308
2025 Q2	$656	Hold	3	–	–	﹤0.01%	249
2025 Q1	$672	Buy	3 +2	+200%	+$551	﹤0.01%	247
2024 Q4	$328	Hold	1	–	–	﹤0.01%	216
2024 Q3	$300	Hold	1	–	–	﹤0.01%	242
2024 Q2	$329	Hold	1	–	–	﹤0.01%	197
2024 Q1	$396	Hold	1	–	–	﹤0.01%	173
2023 Q4	$352	Hold	1	–	–	﹤0.01%	186
2023 Q3	$375	Buy	+1	New	+$387	﹤0.01%	177
2023 Q1	–	Sell	-1	Closed	-$292	–	182
2022 Q4	$235	Hold	1	–	–	﹤0.01%	212
2022 Q3	$0	Hold	1	–	–	﹤0.01%	336
2022 Q2	$302	Buy	+1	New	+$325	﹤0.01%	172
2022 Q1	–	Sell	-1	Closed	-$391	–	165
2021 Q4	$469	Buy	+1	New	+$430	﹤0.01%	160
2021 Q3	–	Hold	0	–	–	–	160
2021 Q2	–	Hold	0	–	–	–	179

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WestEnd Advisors's WST Position: Q1 2026 in Review

WestEnd Advisors held its West Pharmaceutical (WST) position steady in Q1 2026 at 3 shares worth $752. The position accounts for ﹤0.01% of the portfolio, ranked #276.

WestEnd Advisors first reported a position in WST in Q4 2021 and has held it in 15 quarters since. The position peaked at $825 in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

WestEnd Advisors held 3 shares of West Pharmaceutical worth $752 as of Q1 2026.
WestEnd Advisors left its West Pharmaceutical share count unchanged in Q1 2026.
West Pharmaceutical made up ﹤0.01% of WestEnd Advisors's portfolio in Q1 2026, its #276 holding.
WestEnd Advisors first reported a position in West Pharmaceutical in Q4 2021 and has held it in 15 quarters since.
WestEnd Advisors's West Pharmaceutical position peaked at $825 in Q4 2025.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on WestEnd Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.